A environmentally friendly reversed-phase liquid chromatography method for phthalates determination in nail cosmetics

A simple and rapid analytical method was developed for the determination of phthalates, usually employed in nail cosmetic products. The method is based on an ultrasonic extraction of the sample with ethanol-water (90:10, v/v) followed by HPLC separation and quantitation. HPLC was carried out using a C18 column and spectrophotometric detection at 254 nm. A linear gradient elution was performed with ethanol-water starting from 50 to 95% ethanol in 30 min. Standard calibration curves were linear for all the analytes over the concentration range 5-200 μg ml⁻¹ with LOD values of about 0.5 μg ml⁻¹.The proposed green analytical method has been successfully applied for the analysis of commercial samples in order to check the presence of phthalates and to determine their concentration.     

Determination of ternary mixtures of penicillin G, benzathine and procaine by liquid chromatography and factorial design study

In the present work, a rapid and sensitive method for simultaneous determination of penicillin G (PG), benzathine (BE) and procaine (PR) in drug and serum media is introduced. The polar hydro-organic (55/45) mobile phases containing an aqueous solution adjusted to pH = 3.7 and an organic solvent (MeOH) including triethylamine (TEA) and trifluroacetic acid (TFA) are used. The flow rate of 1 ml min⁻¹, a C₈ column (150 mm × 46 mm) with 5 μm i.d. and wavelength at 215 nm are selected for optimal separation condition. The limit of detection (LOD), linear concentration range and relative standard deviation (R.S.D.) of this method for the PG are 1.1 μg ml⁻¹, 10-2400 μg ml⁻¹ and 1.7% and for the BE are 1.2 μg ml⁻¹, 12-2100 μg ml⁻¹ and 1.8% and for the PR are 1.5 μg ml⁻¹, 20-2000 μg ml⁻¹ and 2%, respectively. The factorial design is used for the determination of main and interaction effects of pH, flow rate and concentration of MeOH, TEA and TFA in the separation at two levels. Also, the analysis of variance (ANOVA) table is obtained. The results show that TFA and TEA have higher effect than concentration of MeOH, pH and flow rate factors.     

Ultra-trace level determination of hydroquinone in waste photographic solutions by UV-vis spectrophotometry

A simpler UV-vis spectrophotometric method was investigated for hydroquinone (HQ) determination using KMnO₄ as oxidizing agent for conversion of HQ to p-benzoquinone (BQ) as well as signal enhancer. Various parameters such as analytical wavelength, stability time, temperature, pH, solvent effect and interference of chemicals were checked and parameters optimized by using 1 μg ml⁻¹ standard solution of HQ. Beer's Law was applicable in the range of 0.07-2 μg ml⁻¹ and 0.005-0.05 μg ml⁻¹ at 245.5 nm and at 262 nm for aqueous standard solutions of HQ with linear regression coefficient value of 0.9978 and 0.9843 and detection limit of 0.021 μg ml⁻¹ and 0.0016 μg ml⁻¹ HQ, respectively. Standard deviation of 1.7% and 2.4% was true for 1 μg ml⁻¹ and 0.03 μg ml⁻¹ HQ solution (n = 11) run at respective wavelengths. The method was successfully applied to dilute waste photographic developer samples for free HQ determination.     

Non-equilibrium determination of metoclopramide and tetracaine hydrochloride by sequential injection spectrophotometry

A new sequential injection spectrophotometric method was proposed for the determination of metoclopramide and tetracaine hydrochloride. The method was based on the detection of an unstable red intermediate compound resulting from the reaction of metoclopramide or tetracaine hydrochloride with potassium dichromate, in the presence of sodium oxalate, in sulfuric acid solution. The related reaction mechanisms of this new method have been studied. The experimental conditions were optimized for the stopped-flow and continuous-flow sequential injection models. For continuous flow, the linear range for determination of metoclopramide, the detection limit and the sampling frequency were 13-130 μg ml⁻¹, 9.4 μg ml⁻¹ and 40 samples per hour, respectively. For stopped flow, they were 3-42 μg ml⁻¹, 1.0 μg ml⁻¹ and 18 h⁻¹, respectively. Adopting the continuous-flow model for tetracaine hydrochloride, the linear range was 25-300 μg ml⁻¹, and the detection limit was 18.0 μg ml⁻¹ with sampling frequency of 40 h⁻¹. This method has been used to determine metoclopramide and tetracaine hydrochloride in pharmaceutical preparations, and the results are compared with those determined by the pharmacopoeia method. Statistical analysis reveals that there was no evidence of significant difference between the methods.     

Synchronous fluorescence determination of protein with functionalized CdS nanoparticles as a fluorescence probe

Nanometer-sized fluorescent particles have been successfully synthesized. A synchronous fluorescence method, with high sensitivity and selectivity, has been developed for rapid determination of protein with functionalized CdS as a fluorescence probe. When Δλ=260 nm, maximum synchronous fluorescence is produced at 274 nm at pH 7.0. Under optimal conditions, the calibration graphs are linear over the range 0.1-3.0 μg ml⁻¹ for bovine serum albumin (BSA), 0.1-11.0 μg ml⁻¹ for γ-globulin (γ-G) and 0.1-1.4 μg ml⁻¹ for human serum albumin (HSA), respectively. Limits of determination were 0.01 μg ml⁻¹ for BSA, 0.019 μg ml⁻¹ for γ-G and 0.021 μg ml⁻¹ for HSA, respectively. The relative standard deviations of seven replicate measurements were 1.8% for 1.0 μg ml⁻¹ BSA, 2.2% for 1.0 μg ml⁻¹ γ-G and 2.3% for 1.0 μg ml⁻¹ HSA.     

Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed-phase high-performance liquid chromatography method

A new, accurate, sensitive and fast reversed-phase high-performance liquid chromatography (RP-HPLC) as an analytical method for the quantitative determination of 11 drugs in human urine was worked out, optimized and validated. The objects of analysis were imipenem (IMP), paracetamol (PAR), dipyrone (DPR), vancomycin (VCM), amikacin (AMK), fluconazole (FZ), cefazolin (CFZ), prednisolone (PRE), dexamethasone (DEX), furosemide (FUR) and ketoprofen (KET) belonging to four different groups (antibiotics, analgesic, demulcent and diuretic). For HPLC analysis, diode array (DAD) and fluorescence (FL) detectors were used. The separation of analyzed compounds was conducted by means of a LiChroCART^® Purospher^® C₁₈e (125 mm × 3 mm, particle size 5 μm) analytical column with LiChroCART^® LiChrospher^® C₁₈ (4 mm × 4 mm, particle size 5 μm) pre-column with gradient elution. Analyzed drugs were determined within 20 min. The mobile phase was comprised of various proportions of methanol, acetonitrile and 0.05% trifluoroacetic acid in water. AMK was separated and determined from human urine using ortho-phthaldialdehyde-3-mercaptopropionic acid (OPA-3-MPA) as a fluorescent reagent by RP-HPLC-FL. The following retention times for drugs IMP, PAR, DPR, VCM, AMK, FZ, CFZ, PRE, DEX, FUR and KET in human urine were found: 4.01 min, 4.86 min, 6.71 min, 8.14 min, 9.46 min, 10.01 min, 10.90 min, 13.34 min, 14.06 min, 16.03 min and 18.98 min, respectively. Excellent linearity was obtained for compounds in the range of concentration: 0.35-42 μg ml⁻¹, 0.5-45 μg ml⁻¹, 4.5-38 μg ml⁻¹, 0.25-25 μg ml⁻¹, 0.5-35 μg ml⁻¹, 0.25-22 μg ml⁻¹, 0.03-52 μg ml⁻¹, 0.15-25 μg ml⁻¹, 0.25-28 μg ml⁻¹, 0.05-18 μg ml⁻¹ and 0.15-35 μg ml⁻¹ for IMP, PAR, DPR, VCM, AMK, FZ, CFZ, PRE, DEX, FUR and KET, respectively. The limits of detection (LOD) and limits of quantification (LOQ) for analyzed drugs were calculated in all cases and recovery studies were also performed. Ten human urine samples obtained from patients treated in hospital have been tested. In analyzed samples, one or more drugs from the 11 examined drugs were detected. The concentrations of examined drugs in urine samples ranged between: 1.5-12 μg ml⁻¹ of PAR, 5.2-11.5 μg ml⁻¹ of DPR, 0.13-9.5 μg ml⁻¹ of CFZ and 0.1-8 μg ml⁻¹ of FUR. This method can be successfully applied to routine determination of all these drugs in human urine samples.     

Determination of clarithromycin in rat plasma by HPLC-UV method with pre-column derivatization

A novel high-performance liquid chromatographic (HPLC) method using pre-column derivatization and UV detection at 275 nm for the determination of clarithromycin in rat plasma has been validated. Clarithromycin was extracted from plasma sample spiked with internal standard (erythromycin) under alkaline condition with ethyl ether and derivatizated with trimethylbromosilane. The analyses were run on a C₁₈ column, maintained at 40 °C during elution, using a mobile phase comprised of potassium dihydrogen phosphate (50 mM, pH 6.8, contained 0.7% triethylamine), acetonitrile, and methanol (30:45:25, v/v/v). The standard calibration curve for clarithromycin was linear (r² = 0.9998) over the concentration range of 0.1-10 μg ml⁻¹ in rat plasma. The limit of detection (LOD) and limit of quantitation (LOQ) was 30 ng ml⁻¹ and 0.1 μg ml⁻¹ respectively. The intra- and inter-day assay variability range was 2.6-7.4% and 3.3-8.5%, respectively. This method has been successfully applied to a pharmacokinetic study of clarithromycin in rats.     

Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation product

Two reversed-phase liquid chromatographic (RP-LC) methods have been developed for the determination of sitagliptin phosphate monohydrate (STG). The first method comprised the determination of STG alone in bulk and plasma; and in its pharmaceutical preparation. This method was based on isocratic elution of STG using a mobile phase consisting of potassium dihydrogen phosphate buffer pH (7.8)-acetonitrile (70:30, v/v) at a flow rate of 1 mL min⁻¹ with flourometric detection. The flourometric detector was operated at 267 nm for excitation and 575 nm for emission. In the second method, the simultaneous determination of STG and metformin (MET) in the presence of sitagliptin alkaline degradation product (SDP) has been developed. In this method, the ternary mixture of STG, MET and SDP was separated using a mobile phase consisting of potassium dihydrogen phosphate buffer pH (4.6)-acetonitrile-methanol (30:50:20, v/v/v) at a flow rate of 1 mL min⁻¹ with UV detection at 220 nm. Chromatographic separation in the two methods was achieved on a Symmetry^® Waters C18 column (150 mm × 4.6 mm, 5 μm). Linearity, accuracy and precision were found to be acceptable over the concentration ranges of 0.25-200 μg mL⁻¹ for STG with the first method and 5-160 μg mL⁻¹, 25-800 μg mL⁻¹ for STG and MET, respectively with the second method. The optimized methods were validated and proved to be specific, robust and accurate for the quality control of the cited drugs in pharmaceutical preparations.     

Use of a solid sensing zone implemented with unsegmented flow analysis for simultaneous determination of thiabendazole and warfarin

For the first time, a solid sensing zone implemented with unsegmented flow analysis is described for the simultaneous determination of two pesticides, thiabendazole and warfarin. The system works as a simple and rapid spectrofluorimetric biparameter sensor. The sensor is based on the retention of the analytes on the sensing solid zone (octadecyl silane C₁₈ gel) placed in the detection zone itself into a quartz flow-cell. A temporary sequentiation in the arrival of the analytes to the sensing zone is achieved by on line separation using a pre-column of the same gel placed just before the flow cell. Thiabendazole is determined the first (using methanol 30% (v/v) as carrier/elution solution) because it passes through the pre-column while warfarin is strongly retained in it. Then, warfarin is conveniently eluted from the pre-column (using methanol 50% (v/v) as carrier/elution solution) the intrinsic fluorescence peak height measured at an excitation wavelength of 309 nm and an emission wavelength of 368 nm is used as analytical signal. Using a low sample volume (40 μl), the analytical signal showed a very good linearity in the range 10-800 ng ml⁻¹ and 2-40 μg ml⁻¹ with detection limits of 2.35 ng ml⁻¹ and 0.54 μg ml⁻¹ for thiabendazole and warfarin, respectively. The sensor was satisfactorily applied to the determination of these two analytes in pesticides and pharmaceutical preparations.     

Determination of trace amounts of bromide by flow injection/stopped-flow detection technique using kinetic-spectrophotometric method

A simple, sensitive and selective method for the determination of bromide in seawater by using a flow injection/stopped-flow detection technique was examined. The detection system was developed for a new kinetic-spectrophotometric determination of bromide in the presence of chloride matrix without any extraction and/or separation. The detection was based on the kinetic effect of bromide on the oxidation of methylene blue (MB) with hydrogen peroxide in a strongly acidic solution. Large amounts of chloride could enhance the sensitivity of the method as an activator. The decolorisation of the blue color of MB was used for the spectrophotometric determination of bromide at 746 nm. A stopped-flow approach was used to improve the sensitivity of the measurement and provide good linearity of the calibration over the range of 0-3.2 μg ml⁻¹ of bromide. The relative standard deviation was 0.74% for the determination of 2.4 μg ml⁻¹ bromide (n = 5). The detection limit (3σ) was 0.1 μg ml⁻¹ with a sampling frequency of 12 h⁻¹. The influence of potential interfering ions was studied. The proposed method was applied to the determination of bromide in seawater samples and provided satisfactory results.     

Simultaneous determination of sulfamonomethoxine, sulfadimethoxine, and their hydroxy/N(4)-acetyl metabolites with gradient liquid chromatography in chicken plasma, tissues, and eggs

A simultaneous determination of sulfamonomethoxine, sulfadimethoxine, and their hydroxy/N⁴-acetyl metabolites in chicken plasma, muscle, liver, and eggs using gradient high-performance liquid chromatography (HPLC) with a photo-diode array detector is developed. All the compounds are extracted by a handheld ultrasonic homogenizer with ethanol followed by centrifugation. The separation is performed by a reversed-phase C4 column with a gradient elution (ethanol:1% (v/v) acetic acid, v/v; 10:90 → 20:80). Average recoveries from samples spiked at 0.1-1.0 μg g⁻¹ or μg ml⁻¹ for each drug were >90% with relative standard deviations within 4%. The limits of quantitation were <30 ng g⁻¹ or ng ml⁻¹.     

Sequential flow injection analysis of ammonium and nitrate using gas phase molecular absorption spectrometry

A flow injection method on the basis of gas phase molecular absorption is described for the sequential determination of ammonium and nitrate. Two hundred microliters of sample solution is injected into the flow line. For ammonium determination, the sample zone is directed to a line in which reacts with NaOH (13 M) and produces ammonia. But for nitrate determination, the sample zone is passed through the on-line copperized zinc (Zn/Cu) reduction column and produces ammonium ion and in the follows ammonia. The produced ammonia in both cases is purged into the stream of N₂ carrier gas. The gaseous phase is separated from the liquid phase using a gas-liquid separator and then is swept into a flow through cell, which has been positioned in the cell compartment of an UV-Vis spectrophotometer. The absorbance of the gaseous phase is measured at 194 nm. Under selected conditions for sequential analysis of ammonium and nitrate, linear relations were found between the peak heights of absorption signals and concentrations of ammonium (10-650 μg ml⁻¹) and nitrate (20-800 μg ml⁻¹). The limit of detections for ammonium and nitrate analysis were 8 and 10 μg ml⁻¹, respectively. The relative standard deviations of repeated measurements of 50 μg ml⁻¹ of ammonium and nitrate were 2.0, 2.9%, respectively. Maximum sampling rate was about 40 samples/h. The method was applied to the determination of ammonium in pharmaceutical products and the sequential determination of ammonium and nitrate in spiked water samples.     

Application of the spectral correction method and "neural networks" for simultaneous determination of V(V) and Al(III)

Simultaneous determination of V(V) and Al(III) was performed by application of neural networks when the calibration matrix was performed using β-correction spectra. Two reactions between V(V) and Al(III) and Alizarin Red S (ARS) as a ligand have been investigated and applied for the simultaneous spectrophotometric determination of these metal ions. The parameters controlling behavior of the system were investigated and optimum conditions selected. Feed-forward neural networks have been trained to quantify considered metal ions in mixtures under optimum conditions. Sigmoidal functions were used in the hidden and output layers. Determinations were made over the concentration range 0.10-7.80 μg ml⁻¹ of V(V) and 0.11-4.20 μg ml⁻¹ of Al(III). Applying this method satisfactorily to simultaneous determination of these metal ions in several synthetic solutions with total relative standard error less than 4.02% validated the proposed method.     

Direct determination of kanamycin in raw materials, veterinary formulation and culture media using a novel liquid chromatography-evaporative light scattering method

A novel method for the direct determination of kanamycin A and its minor component kanamycin B was developed and validated based on reversed phase liquid chromatography with evaporative light scattering detector (ELSD). ELSD response to kanamycins was found to be enhanced by: (a) decrease of peak width and asymmetry (obtained by controlling the mobile phase acidity or ratio of organic solvent to water), (b) use of ion-pairing acidic reagents of increased molecular mass, and (c) increase of mobile phase volatility. Utilizing an Spherisorb ODS-2 C₁₈ column, the selected optimized mobile phase was water-acetonitrile (60:40, v/v), containing 11.6 mM heptafluorobutyric acid (isocratic elution with flow rate of 1.0 ml min⁻¹). Kanamycin A was eluted at 3.9 min and kanamycin B at 5.0 min with a resolution of 2.7. Logarithmic calibration curves were obtained from 0.6 to 28 μg ml⁻¹ (r > 0.9998) for kanamycin A and 4-36 μg ml⁻¹ (r > 0.9994) for kanamycin B, with a LOD equal to 0.20 and 1.4 μg ml⁻¹, respectively.In kanamycin acid sulfate pharmaceutical raw materials, the simultaneous determination of sulfate (t_R = 2.1 min, LOD = 2.3 μg ml⁻¹, %R.S.D. = 1.7, r > 0.9998) and kanamycins was feasible. No significant difference (t-test) was found between the results of the developed LC-ELSD method and those of reference methods, while recovery from kanamycin B spiked samples ranged from 95 to 105%. The developed method was also applied with very good accuracy for the determination of kanamycin A in veterinary formulation (%recovery 95-103, %R.S.D. < 1.4, n = 3) and for the determination of kanamycins A and B in bacteria culture media (%recovery 102 and 99, respectively).     

Determination of palladium in various samples by atomic absorption spectrometry after preconcentration with dimethylglyoxime on silica gel

A preconcentration method based on the adsorption of palladium-dimethylglyoxime (DMG) complex on silica gel for the determination of palladium at trace levels by atomic absorption spectrometry (AAS) has been developed. The retained palladium as Pd(DMG)₂ complex was eluted with 1 mol l⁻¹ HCl in acetone. The effect of some analytical parameters such as pH, amount of reagent and the sample volume on the recovery of palladium was examined in synthetic solutions containing street dust matrix. The influence of some matrix ions on the recovery of palladium was investigated by using the developed method when the elements were present both individually and together. The results showed that 2500 μg ml⁻¹ Na⁺, K⁺, Mg²⁺, Al³⁺ and Fe³⁺; 5000 μg ml⁻¹ Ca²⁺ ; 500 μg ml⁻¹ Pb²⁺; 125 μg ml⁻¹ Zn²⁺; 50 μg ml⁻¹ Cu²⁺ and 25 μg ml⁻¹ Ni²⁺ did not interfere with the palladium signal. At the optimum conditions determined experimentally, the recovery for palladium was found to be 95.3±1.2% at the 95% confidence level. The relative standard deviation and limit of detection (3s/b) of the method were found to be 1.7% and 1.2 μg l⁻¹, respectively. In order to determine the adsorption behaviour of silica gel, the adsorption isotherm of palladium was studied and the binding equilibrium constant and adsorption capacity were calculated to be 0.38 l mg⁻¹ and 4.06 mg g⁻¹, respectively. The determination of palladium in various samples was performed by using both flame AAS and graphite furnace AAS. The proposed method was successfully applied for the determination of palladium in the street dust, anode slime, rock and catalytic converter samples.     

Development of an optical chemical sensor based on 2-(5-bromo-2-pyridylazo)-5-(diethylamino)phenol in Nafion for determination of nickel ion

An optical chemical sensor based on immobilization of 2-(5-bromo-2-pyridylazo)-5-(diethylamino)phenol (Br-PADAP) in Nafion membrane is described. The membranes were cast onto glass substrates and were used for the determination of nickel in aqueous solutions by spectrophotometry. The sensor system is highly transparent, mechanically stable and showed no evidence of reagent leaching. The influence of several parameters such as pH, ligand concentration, and type and concentration of regenerating solution were optimized. The sensor system showed good sensitivity in the range 0.5-20 μg ml⁻¹ with a detection limit of 0.3 μg ml⁻¹ Ni(II). The sensor has been incorporated into a home-made flow-through cell for determination of nickel in flowing streams with improved sensitivity, precision and detection limit. The calibration curve in the flow system was linear in the range 0.1-16 μg ml⁻¹ with a detection limit of 0.07 μg ml⁻¹. The sensor is easily regenerated by dilute nitric acid solution. The proposed method was successfully applied to the determination of nickel content in vegetable oil and chocolate samples and the results were compared with those obtained using atomic absorption spectrometry.     

Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation

A simple isocratic reversed-phase high-performance liquid chromatographic method (RP-HPLC) was developed for the simultaneous determination of buprenorphine hydrochloride, naloxone hydrochloride dihydrate and its major impurity, noroxymorphone, in pharmaceutical tablets. The chromatographic separation was achieved with 10 mmol L⁻¹ potassium phosphate buffer adjusted to pH 6.0 with orthophosphoric acid and acetonitrile (17:83, v/v) as mobile phase, a C-18 column, Perfectsil Target ODS3 (150 mm × 4.6 mm i.d., 5 μm) kept at 35 °C and UV detection at 210 nm. The compounds were eluted isocratically at a flow rate of 1.0 mL min⁻¹. The average retention times for naloxone, noroxymorphone and buprenorphine were 2.4, 3.8 and 8.1 min, respectively. The method was validated according to the ICH guidelines. The validation characteristics included accuracy, precision, linearity, range, specificity, limit of quantitation and robustness. The calibration curves were linear (r > 0.996) over the concentration range 0.22-220 μg mL⁻¹ for buprenorphine hydrochloride and 0.1-100 μg mL⁻¹ for naloxone hydrochloride dihydrate and noroxymorphone. The recoveries for all three compounds were above 96%. No spectral or chromatographic interferences from the tablet excipients were found. This method is rapid and simple, does not require any sample preparation and is suitable for routine quality control analyses.     

Fast simultaneous spectrophotometric determination of naphazoline nitrate and methylparaben by sequential injection chromatography

Fast simultaneous determination of naphazoline nitrate and methylparaben in pharmaceuticals using separation method based on a novel reversed-phase sequential injection chromatography (SIC) is described in this contribution as an alternative to classical HPLC. A Chromolith™ Flash RP-18e (25 mm × 4.6 mm) column (Merck^®, Germany) and a FIAlab^® 3000 system (USA) with a six-port selection valve and 5.0 ml syringe pump were used for sequential injection chromatographic separations in our study. The mobile phase used was methanol/water (40:65, v/v), pH 5.2 adjusted with triethylamine 0.8 μl ml⁻¹ and acetic acid, at flow rate 0.9 ml min⁻¹. UV detection provided by DAD detector and two wavelengths were simultaneously monitored for increasing sensitivity of determination. Detector was set up at 220 nm for naphazoline nitrate and 256 nm for methylparaben and ethylparaben (IS). There is no necessity to use pre-adjustment of sample of nasal drops (only dilution with mobile phase) so the time of the whole analysis is very short. The validation parameters have shown good results: linearity of determination for both components (naphazoline nitrate and methylparaben), correlation coefficient >0.999; repeatability of determination (R.S.D.) in the range 0.5-1.6% at three different concentration levels, detection limits 0.02 μg ml⁻¹ (naphazoline nitrate) and 0.20 μg ml⁻¹ (methylparaben and ethylparaben), and recovery from the pharmaceutical preparations in the range 100.06-102.55%. The chromatographic resolution between peaks of compounds was more than 4.0 and analysis time was less than 4 min under the optimal conditions. The advantages and drawbacks of SIC against classical HPLC are discussed showing that SIC can be an advantageous alternative in many cases.     

Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography

A simple, reproducible and efficient dual separation mode high performance liquid chromatographic (HPLC) method was developed for simultaneous determination of antihypertensive drug combinations including; hydrochlorothiazide (HCTZ), valsartan (VAL), amiloride (AML) and captopril (CAP). The newly developed Platinum™ column, which provides a dual-mode separation with its polar and non-polar sites, was used for rapid separation of these co-administered drugs. Good resolution was obtained when Platinum™ column was used compared with C₁₈ column. Additionally, simple isocratic mode with mobile phase containing methanol and 0.02 mole L⁻¹ phosphate buffer adjusted to pH 3.0 (45:55, v/v) was used for separation. The flow rate was 0.5 mL min⁻¹ and effluent was monitored at 270 nm. All the investigated drugs were completely separated within less than 6 min. The linearity range obtained for the developed HPLC method was 0.5-100 μg mL⁻¹ with detection limits of 0.13-1.2 μg mL⁻¹ for all the studied drugs. The method was validated in accordance with the requirements of ICH guidelines and shown to be suitable for intended applications. The method was successfully used for determination of the studied drugs in pure form and pharmaceutical dosage forms without prior need for separation. The method is valuable for quality control laboratories for simultaneous determination of these co-administered antihypertensive drugs in binary, ternary and quaternary mixtures.     

Micro determination of ascorbic acid using methyl viologen

A new simple and sensitive analytical spectrophotometric method is developed for the determination of ascorbic acid reduces methyl viologen to form a stable blue coloured free radical ion. This method has a sensitivity and lower limit detection of 0.1 μg ml⁻¹ of ascorbic acid (0.1 ppm) which is comparable to the flow injection analysis reported earlier. Beer's law is obeyed over the concentration range of 1.0-10 μg ml⁻¹ of ascorbic acid per 10 ml of the final solution (0.1-1.0 μg ml⁻¹) at 600 nm. The molar absorptivity and Sandell's sensitivity were found to be 1.5 × 10⁵ ± 100 l mol⁻¹ cm⁻¹ and 0.001 μg cm⁻², respectively. The method has been applied to the determination of ascorbic acid in food, pharmaceuticals and biological samples.